UK UKCA Marking & MHRA Medical Device Registration
Navigate the post-Brexit UK regulatory landscape with confidence. NexorTest Technologies provides end-to-end UKCA marking and MHRA registration consulting for medical device manufacturers seeking compliant access to the Great Britain and Northern Ireland markets.
Your Pathway to UK Market Access
The UK post-Brexit regulatory framework offers multiple routes for medical device market entry. Understanding which pathway applies to your device is critical for efficient, compliant registration.
UKCA Marking Route
The primary route for placing medical devices on the Great Britain market. Requires conformity assessment under UK regulations, involvement of a UK Approved Body for higher-risk devices, and MHRA registration.
Who is this for?
Manufacturers seeking long-term, standalone UK market access independent of EU CE marking. Ideal for devices without existing CE certification or those planning early transition to UKCA.
CE Recognition Route
Leverage existing EU CE marking under the UK’s transitional provisions. EU MDR certified devices are accepted in GB until June 30, 2030, and MDD certified devices until June 30, 2028.
Who is this for?
Manufacturers who already hold valid CE certification and want immediate UK market access without duplicating conformity assessment. A practical bridge while the UKCA regime finalizes.
International Reliance Route
The upcoming MHRA international reliance framework will recognize approvals from trusted regulators (FDA, EU Notified Bodies, TGA), streamlining UK market entry and reducing duplication.
Who is this for?
Manufacturers with existing approvals from recognized international regulators who wish to leverage those for expedited UK access under the new framework expected in 2026.
Our UKCA & MHRA Consulting Services
Comprehensive regulatory support across every aspect of UK medical device market access, from initial strategy through post-market compliance.
UKCA Conformity Assessment
Full conformity assessment support including classification, essential requirements analysis, technical documentation, and Declaration of Conformity preparation aligned with UK MDR.
MHRA Device Registration
End-to-end MHRA registration including manufacturer and device registration, submission management, and liaison with MHRA throughout the approval process.
UK Responsible Person Services
Comprehensive UKRP services for non-UK manufacturers including regulatory representation, documentation maintenance, adverse event reporting, and MHRA communications.
CE-to-UKCA Transition
Strategic planning and execution for transitioning from CE marking to UKCA marking, including gap analysis, documentation updates, and timeline management.
Northern Ireland Compliance
Navigate the Windsor Framework requirements for Northern Ireland, where EU MDR applies. Dual compliance strategies for manufacturers serving both GB and NI markets.
QMS Alignment UK MDR
Align your Quality Management System with UK-specific regulatory requirements, ensuring compliance with ISO 13485 and UK MDR expectations for ongoing market access.
Clinical Evaluation UK
Clinical evaluation and clinical investigation support tailored to UK requirements, including MHRA clinical investigation applications and post-market clinical follow-up.
Post-Market Surveillance UK
Establish and maintain UK-compliant post-market surveillance systems, vigilance reporting to MHRA, and periodic safety update reports specific to the UK market.
SaMD UK Registration
Specialized consulting for Software as a Medical Device in the UK market, including classification under UK rules, clinical evidence requirements, and cybersecurity compliance.
Why Choose NexorTest for UK Market Access
With deep expertise in UK post-Brexit medical device regulations and established relationships with the MHRA, NexorTest Technologies is your trusted partner for navigating the evolving UK regulatory landscape.
Post-Brexit Regulatory Expertise
Our team has been at the forefront of UK regulatory changes since Brexit, providing up-to-date guidance on UKCA marking and MHRA requirements as the framework evolves.
Established UKRP Capability
We serve as UK Responsible Person for manufacturers worldwide, offering a seamless single point of contact for all UK regulatory obligations and MHRA correspondence.
Dual GB/NI Strategy
Navigate the complexities of serving both Great Britain and Northern Ireland markets with our integrated compliance approach under UKCA and Windsor Framework requirements.
Global Regulatory Synergy
Leverage our multi-market expertise to align UK registrations with your FDA, EU MDR, and other international submissions, reducing duplication and accelerating timelines.
Our 6-Step UK Registration Process
A proven, systematic approach to UKCA marking and MHRA registration that minimizes delays and ensures first-time approval.
UK Regulatory Strategy & Gap Analysis
Assess your device classification, existing certifications, and identify gaps against UK-specific requirements including UKCA conformity and MHRA expectations.
UKCA Conformity Assessment Planning
Determine the appropriate conformity assessment route, select a UK Approved Body if required, and plan testing and documentation activities.
Testing & Technical Documentation
Conduct UK-specific testing, compile the technical file, and prepare the Declaration of Conformity in alignment with UK MDR requirements.
UK Responsible Person Appointment
Appoint a UK Responsible Person for non-UK manufacturers to fulfill regulatory obligations and act as the MHRA point of contact.
MHRA Registration & Submission
Register the device and manufacturer with the MHRA, submit all required documentation, and manage the review process through to approval.
Market Entry & Ongoing Compliance
Affix UKCA marking, launch in the UK market, and maintain ongoing post-market surveillance, vigilance, and periodic safety updates.
Industries We Serve
Our UK regulatory consulting expertise spans the full spectrum of medical device and healthcare technology sectors.
- Cardiovascular Devices
- Orthopaedic Implants
- In Vitro Diagnostics (IVD)
- Surgical Instruments
- Dental Devices
- Ophthalmic Devices
- Digital Health / SaMD
- Respiratory Devices
- Wound Care
- Patient Monitoring
- Imaging & Radiology
- Renal & Dialysis
- AI-Enabled Devices
- Neurology Devices
- Point-of-Care Testing
- Infusion & Drug Delivery
Frequently Asked Questions
Expert answers to the most common questions about UKCA marking and MHRA medical device registration.
What is UKCA marking for medical devices?
The UKCA (UK Conformity Assessed) mark is the UK’s post-Brexit product marking for medical devices placed on the market in Great Britain (England, Scotland, and Wales). It replaces the CE mark for the GB market and demonstrates that a device conforms to the relevant UK regulations. UKCA marking requires conformity assessment by a UK Approved Body for higher-risk devices and a Declaration of Conformity from the manufacturer.
Can I still use CE marking in the UK?
Yes, under transitional arrangements. CE marked devices certified under the EU MDR (2017/745) remain valid in Great Britain until June 30, 2030. Devices certified under the older MDD (93/42/EEC) are accepted until June 30, 2028. After these deadlines, UKCA marking will be required for the GB market. Northern Ireland continues to accept CE marking under the Windsor Framework.
What is a UK Responsible Person (UKRP)?
A UK Responsible Person (UKRP) is a mandatory appointed representative for non-UK manufacturers who wish to place medical devices on the Great Britain market. The UKRP must be established in the UK and takes on regulatory responsibilities including MHRA registration, maintaining documentation, reporting adverse events, and acting as the point of contact for the regulatory authority.
When do UKCA marking requirements become mandatory?
UKCA marking becomes mandatory once the transitional acceptance periods for CE marking expire. For EU MDR certified devices, this is July 1, 2030. For MDD certified devices, this is July 1, 2028. The UK government is developing a new regulatory framework expected in 2026 that will incorporate an international reliance model, which may affect these timelines. Manufacturers should plan their transition strategy well in advance.
How does Northern Ireland differ from Great Britain?
Under the Windsor Framework, Northern Ireland continues to follow EU rules for medical devices. This means CE marking (not UKCA) is required for devices placed on the Northern Ireland market. Devices must comply with the EU MDR or EU IVDR and be certified by an EU Notified Body. Devices lawfully placed on the Northern Ireland market can also be sold in Great Britain, but the reverse is not automatically true.
What is the MHRA international reliance framework?
The MHRA international reliance (IR) framework is a planned regulatory approach where the MHRA would recognize approvals or assessments from trusted international regulators (such as the FDA, EU Notified Bodies, or TGA) to streamline the UK approval process. This is expected to be part of the new UK medical device regulations anticipated in 2026, aiming to reduce duplication and accelerate patient access to safe, innovative devices.
How long does MHRA registration take?
MHRA device registration timelines vary depending on device classification and completeness of documentation. For Class I devices, registration can be completed within 4-6 weeks. Higher-risk devices (Class IIa, IIb, III) that require UK Approved Body involvement may take 3-6 months or longer. Having a pre-existing CE certificate and complete technical documentation can significantly expedite the process.
Can NexorTest serve as UK Responsible Person?
Yes, NexorTest Technologies offers UK Responsible Person (UKRP) services for non-UK manufacturers. As your appointed UKRP, we handle MHRA registration, maintain required documentation, manage adverse event reporting, facilitate regulatory correspondence, and ensure ongoing compliance with UK medical device regulations. This is ideal for international manufacturers seeking efficient, compliant UK market access.
Ready to Enter the UK Market?
Get a free, no-obligation assessment of your device’s UK regulatory pathway. Our UKCA and MHRA specialists are ready to guide you from strategy to market launch.
Accreditations & Certifications
Accredited Labs
QMS Certified
National Accreditation
Bureau of Indian Standards
Recognised Consultant